Baldwin, Colleagues Call on Purdue Pharma to Cancel $1.3 Million Bonus for CEO
"By maintaining the aggressive incentive plan for Mr. Landau, the Board is showing that it does not recognize the role the incentive program played in accelerating the opioid crisis into a national tragedy."
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin led 10 of her Senate colleagues in sending a letter to Purdue Pharma’s Board of Directors, calling on them to cancel the reported $1.3 million bonus they are planning to give to Purdue Pharma CEO Craig Landau. Attorneys General from 24 states, including Wisconsin, have argued that Landau should not collect a bonus, and on Thursday, a bankruptcy judge is expected to issue a decision on whether the CEO can collect it.
From the letter, the Senators write,“We write to you today with concerns about the $1.3 million incentive bonus payment you have proposed to make to Purdue chief executive officer Craig Landau while your company is in Chapter 11 bankruptcy. Mr. Landau is a named defendant in multiple lawsuits, which allege he personally designed Purdue’s intentionally deceptive opioid marketing campaign. Further, the payment is based on aggressive performance incentives similar to those used to encourage opioid sales. As such, we ask that you cancel the incentive payment to Mr. Landau and reevaluate your incentive payment plan to ensure your company puts patient safety ahead of profits.”
The Senators continue,“By maintaining the aggressive incentive plan for Mr. Landau, the Board is showing that it does not recognize the role the incentive program played in accelerating the opioid crisis into a national tragedy. While the filings indicate that Purdue’s sales incentive plan will not pay bonuses for opioid sales, it is not clear that the operating profit incentive will exclude opioid sales from its calculation.”
The company’s recently-submitted compensation proposal would incentivize Mr. Landau to meet aggressive sales targets, and could result in the unwarranted prescription and irresponsible distribution of opioids and other addictive drugs. While the proposal indicates that Purdue’s sales incentive plan will not pay bonuses for opioid sales, it is not clear that the operating profit incentive will exclude opioid sales from its calculation. In their letter, the Senators highlight that there is no indication the very compensation policies that encouraged its employees to allegedly deceive doctors and patients to sell opioids have been removed from the current compensation plan to sell other drugs.
They conclude,“In closing, we again urge you to cancel your proposed incentive bonus payment to Mr. Landau, and reevaluate your entire incentive pay program to ensure that your company puts patient safety ahead of profits.”
The full letter is available here. An online version of this release is available here.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.
More about the Opioid Crisis
- Serenity Inns: A Proven Lifesaving Facility Denied Critical State Funding - Serenity Inns - Nov 19th, 2024
- Milwaukee County Outreach Team Going Door-to-Door Handing Out Narcan in High Overdose Areas - Evan Casey - Nov 14th, 2024
- DHS Launches New System to Help Communities Track and Respond to Overdose - Wisconsin Department of Health Services - Nov 14th, 2024
- Attorney General Kaul and Bipartisan Coalition of 30 States Announce Settlement with Kroger Over Opioid Crisis - Wisconsin Department of Justice - Nov 6th, 2024
- Baldwin Calls on Biden Administration to Investigate China’s Role in Fueling the Fentanyl Crisis - U.S. Sen. Tammy Baldwin - Oct 23rd, 2024
- Baldwin Brings Home $750,000 for Northeastern Wisconsin to Combat Fentanyl and Opioid Epidemic - U.S. Sen. Tammy Baldwin - Sep 27th, 2024
- AG Kaul Meets with EMS Leave Behind Program Recipients - Wisconsin Department of Justice - Sep 17th, 2024
- MKE County: Crowley Signs Opioid Program Funding - Graham Kilmer - Sep 10th, 2024
- Serenity Inns Opens New Addiction Treatment Center in Milwaukee - Serenity Inns - Aug 14th, 2024
- MKE County: County Nearly Doubles Narcan Vending Machines - Graham Kilmer - Aug 12th, 2024
Read more about Opioid Crisis here
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Baldwin Announces Over $101 Million to Lower Energy Costs for Wisconsin Families
Nov 18th, 2024 by U.S. Sen. Tammy BaldwinFunding comes from Baldwin-backed government funding legislation and Bipartisan Infrastructure Law